Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Peking University Cancer Hospital & Institute
Peking University
Beijing Friendship Hospital
NGM Biopharmaceuticals, Inc
Imperial College London
Jinling Hospital, China
Hospital Beatriz Ângelo
Samsung Medical Center
University Hospital, Essen
Sandwell & West Birmingham Hospitals NHS Trust
Suzhou Immunofoco Biotechnology Co., Ltd
Centre Hospitalier Universitaire Vaudois
Guangxi Medical University
P. Herzen Moscow Oncology Research Institute
Beijing Friendship Hospital
Panolos Bioscience
Universitair Ziekenhuis Brussel
Shandong Provincial Hospital
Zhejiang University
University of Maia
National Institute of Public Health, Slovenia
Celon Pharma SA
China Medical University, China
Aurigene Discovery Technologies Limited
Henan Cancer Hospital
First People's Hospital of Hangzhou
Guangdong Provincial People's Hospital
Regina Elena Cancer Institute
The First Affiliated Hospital of Zhengzhou University
Chinese PLA General Hospital
RenJi Hospital
Hebei Medical University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Fujian Cancer Hospital
Chongqing Precision Biotech Co., Ltd
Kidney Cancer Research Bureau
Zhejiang University
RemeGen Co., Ltd.
RemeGen Co., Ltd.
Affiliated Hospital to Academy of Military Medical Sciences
Royal Marsden NHS Foundation Trust
Changhai Hospital
Assiut University
Zhejiang Cancer Hospital
National Cheng-Kung University Hospital
Icahn School of Medicine at Mount Sinai
Ajou University School of Medicine
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Tang-Du Hospital